Cardiometabolic health in people with HIV: expert consensus review

Rachel L Batterham1,2, Roger J Bedimo3,4, Ricardo S Diaz5

  • 1UCL Division of Medicine, UCL School of Life and Medical Sciences, University College London, Gower Street, London WC1E 6BT, UK.

Insights

People with HIV face higher cardiometabolic risks. Expert consensus yielded recommendations for holistic care, including regular assessments and lifestyle advice to manage these health concerns.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • People with HIV (Human Immunodeficiency Virus) exhibit an elevated risk of cardiometabolic health issues compared to the general population.
  • Antiretroviral therapy (ART) can influence cardiometabolic health, necessitating careful management.
  • Existing knowledge gaps hinder optimal cardiometabolic health outcomes in individuals with HIV.

Purpose of the Study:

  • To establish consensus data statements and clinical recommendations for improving cardiometabolic health in people with HIV.
  • To provide expert guidance for healthcare professionals managing cardiometabolic risks in this population.

Main Methods:

  • A comprehensive literature review of 281 sources (2016-2022) was performed.
  • A modified Delphi method involving 16 international experts was employed.
  • Consensus was reached through workshops and surveys to refine data statements and recommendations.

Main Results:

  • Ten data statements were agreed upon, highlighting increased cardiometabolic risks and the impact of ART.
  • Five significant data gaps were identified to guide future research.
  • Fourteen clinical recommendations were developed, emphasizing a holistic care approach.

Conclusions:

  • Expert consensus provides crucial guidance for managing cardiometabolic health in people with HIV.
  • Recommendations focus on regular assessments, lifestyle counseling, and ART management.
  • Addressing cardiometabolic risks is essential for comprehensive HIV care and improved patient outcomes.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
30
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
322
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
268
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K